Lam Research Corporation $LRCX Shares Acquired by Northwest & Ethical Investments L.P.

Northwest & Ethical Investments L.P. lifted its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 2.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,370 shares of the semiconductor company’s stock after purchasing an additional 900 shares during the period. Northwest & Ethical Investments L.P.’s holdings in Lam Research were worth $3,151,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of LRCX. MIG Capital LLC grew its holdings in Lam Research by 269.8% during the 2nd quarter. MIG Capital LLC now owns 31,417 shares of the semiconductor company’s stock valued at $3,058,000 after buying an additional 22,921 shares during the last quarter. Country Trust Bank purchased a new stake in shares of Lam Research in the second quarter valued at $39,000. J.W. Cole Advisors Inc. lifted its position in shares of Lam Research by 2.8% in the second quarter. J.W. Cole Advisors Inc. now owns 12,236 shares of the semiconductor company’s stock valued at $1,191,000 after acquiring an additional 337 shares in the last quarter. Boston Partners boosted its stake in shares of Lam Research by 36.4% during the second quarter. Boston Partners now owns 3,205,478 shares of the semiconductor company’s stock valued at $312,012,000 after acquiring an additional 855,116 shares during the last quarter. Finally, Oak Associates Ltd. OH increased its position in Lam Research by 133.9% during the 2nd quarter. Oak Associates Ltd. OH now owns 57,638 shares of the semiconductor company’s stock worth $5,610,000 after purchasing an additional 33,000 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Stock Up 2.1%

Shares of LRCX opened at $155.14 on Thursday. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $167.15. The company’s fifty day moving average is $146.09 and its two-hundred day moving average is $113.79. The firm has a market cap of $194.86 billion, a PE ratio of 34.17, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period last year, the company posted $0.86 EPS. The business’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be issued a $0.26 dividend. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on LRCX shares. Wells Fargo & Company raised their price target on shares of Lam Research from $135.00 to $145.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 23rd. Berenberg Bank upped their price objective on shares of Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Evercore ISI lifted their target price on shares of Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a research note on Thursday, October 23rd. Weiss Ratings reiterated a “buy (b)” rating on shares of Lam Research in a report on Monday. Finally, JPMorgan Chase & Co. raised their price objective on Lam Research from $113.00 to $165.00 and gave the stock an “overweight” rating in a report on Thursday, October 23rd. Twenty-six analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and a consensus target price of $152.17.

Insider Transactions at Lam Research

In other news, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction that occurred on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the transaction, the director owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is currently owned by company insiders.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.